Arena Pharmaceuticals Inc (NASDAQ:ARNA)

40.80
Delayed Data
As of Feb 16
 +0.03 / +0.07%
Today’s Change
11.30
Today|||52-Week Range
41.92
+20.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line39.1M-22.5M-23.6M-30.6M
 
 
 
 
 
Depreciation2.2M1.8M1.8M1.8M
 
 
 
 
 
Total Other Cash Flow23.4M1.9M1.8M11.8M
 
 
 
 
 
Funds From Operations64.7M-18.8M-20.0M-17.0M
 
 
 
 
 
Funds From/For Other Operating Expenses73.4M-2.5M5.9M1.4M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.7M-16.3M-25.9M-18.3M
 
 
 
 
 
 
InvestingCapital Expenditures-306.0K-49.0K-41.0K-1.0K
 
 
 
 
 
Fixed Asset Disposal168.0K0.000.00789.0K
 
 
 
Other Investing - Sources--94.0K-4.0K1.0K
 
 
 
 
Net Cash Flow Investing-233.0K45.0K-45.0K789.0K
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings0.00--------
Long Term Debt Reduction-790.0K-816.0K-868.0K-904.0K
 
 
 
 
 
Net Proceeds Stock Sale82.0K5.3M76.2M166.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing320.0K0.000.000.00
 
 
Other Uses - Financing--0.000.000.00--
Net Cash Flow - Financing-388.0K4.5M75.4M165.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.6M578.0K1.8M-434.0K
 
 
 
 
 
 
Net Change In Cash-9.3M-11.8M49.4M148.4M